BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38271010)

  • 21. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
    Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
    Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues.
    Amani A; Alizadeh MR; Yaghoubi H; Nohtani M
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing Targeted Therapy in Hepatocellular Carcinoma through a pH-Responsive Delivery System: Folic Acid-Modified Polydopamine-Paclitaxel-Loaded Poly(3-hydroxybutyrate-
    Wu M; Wang Q; Peng Y; Liang X; Lv X; Wang S; Zhong C
    Mol Pharm; 2024 Feb; 21(2):581-595. PubMed ID: 38131328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles.
    Nemati M; Bani F; Sepasi T; Zamiri RE; Rasmi Y; Kahroba H; Rahbarghazi R; Sadeghi MR; Wang Y; Zarebkohan A; Gao H
    Mol Pharm; 2021 Dec; 18(12):4341-4353. PubMed ID: 34779630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic Acid and Poly(ethylene glycol) Decorated Paclitaxel Nanocrystals Exhibit Enhanced Stability and Breast Cancer-Targeting Capability.
    Zhao J; Du J; Wang J; An N; Zhou K; Hu X; Dong Z; Liu Y
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):14577-14586. PubMed ID: 33728919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer.
    Guo F; Yu N; Jiao Y; Hong W; Zhou K; Ji X; Yuan H; Wang H; Li A; Wang G; Yang G
    Drug Deliv; 2021 Dec; 28(1):1709-1721. PubMed ID: 34463174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
    Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q
    J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Folate Modified Long Circulating Nano-Emulsion as a Promising Approach for Improving the Efficiency of Chemotherapy Drugs in Cancer Treatment.
    Song B; Wu S; Li W; Chen D; Hu H
    Pharm Res; 2020 Nov; 37(12):242. PubMed ID: 33188481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced apoptotic and anticancer potential of paclitaxel loaded biodegradable nanoparticles based on chitosan.
    Gupta U; Sharma S; Khan I; Gothwal A; Sharma AK; Singh Y; Chourasia MK; Kumar V
    Int J Biol Macromol; 2017 May; 98():810-819. PubMed ID: 28189791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine serum albumin and folic acid-modified aurum nanoparticles loaded with paclitaxel and curcumin enhance radiotherapy sensitization for esophageal cancer.
    Gao G; Zhou W; Jiang X; Ma J
    Int J Radiat Biol; 2024; 100(3):411-419. PubMed ID: 37934908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabrication and study of curcumin loaded nanoparticles based on folate-chitosan for breast cancer therapy application.
    Esfandiarpour-Boroujeni S; Bagheri-Khoulenjani S; Mirzadeh H; Amanpour S
    Carbohydr Polym; 2017 Jul; 168():14-21. PubMed ID: 28457434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs.
    Park EK; Lee SB; Lee YM
    Biomaterials; 2005 Mar; 26(9):1053-61. PubMed ID: 15369694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.
    Muthoosamy K; Abubakar IB; Bai RG; Loh HS; Manickam S
    Sci Rep; 2016 Sep; 6():32808. PubMed ID: 27597657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy.
    Xiong K; Zhang Y; Wen Q; Luo J; Lu Y; Wu Z; Wang B; Chen Y; Zhao L; Fu S
    Int J Pharm; 2020 Nov; 589():119875. PubMed ID: 32919003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of targeting ligand designation of self-assembly chitosan-poloxamer nanogels loaded Paclitacel on inhibiting MCF-7 cancer cell growth.
    Nguyen VT; Doan P; Nguyen DT; Doan VD; Dao TP; Plavskii V; Nguyen BT; Tran NQ
    J Biomater Sci Polym Ed; 2022 Mar; 33(4):426-442. PubMed ID: 34641768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
    Yu DH; Lu Q; Xie J; Fang C; Chen HZ
    Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.